UK Votes To Leave The EU – What's Next For The Life Sciences?
This article was originally published in The Gray Sheet
The UK government will have to engage in many years of bargaining over its future relationship with the EU, whether as part of the single market or under the umbrella of the World Trade Organization, as well with the countries with which the EU has trade agreements. What this means precisely for the device industry and oversight of devices in the UK remains to be seen.
You may also be interested in...
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
AMD patients in the UK can legitimately be given compounded bevacizumab (Roche’s Avastin) after the appeals court said NHS trusts could offer a drug off-label for economic reasons where there were no safety or efficacy concerns.